| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Poor prognosis in carcinoma is associated with a gene expression signature of aberrant PTEN tumor suppressor pathway activity.
|
Proc Natl Acad Sci U S A
|
2007
|
5.44
|
|
2
|
The CD44+/CD24- phenotype is enriched in basal-like breast tumors.
|
Breast Cancer Res
|
2008
|
4.63
|
|
3
|
Identification of subtypes in human epidermal growth factor receptor 2--positive breast cancer reveals a gene signature prognostic of outcome.
|
J Clin Oncol
|
2010
|
2.49
|
|
4
|
Pooled analysis of prognostic impact of urokinase-type plasminogen activator and its inhibitor PAI-1 in 8377 breast cancer patients.
|
J Natl Cancer Inst
|
2002
|
2.25
|
|
5
|
Loss of Wnt-5a protein is associated with early relapse in invasive ductal breast carcinomas.
|
Cancer Res
|
2002
|
1.93
|
|
6
|
Basal-like phenotype is not associated with patient survival in estrogen-receptor-negative breast cancers.
|
Breast Cancer Res
|
2007
|
1.91
|
|
7
|
Diagnostic and prognostic gene expression signatures in 177 soft tissue sarcomas: hypoxia-induced transcription profile signifies metastatic potential.
|
BMC Genomics
|
2007
|
1.71
|
|
8
|
Does analysis of biomarkers in tumor cells in lymph node metastases give additional prognostic information in primary breast cancer?
|
World J Surg
|
2010
|
1.68
|
|
9
|
Patterns of chromosomal imbalances defines subgroups of breast cancer with distinct clinical features and prognosis. A study of 305 tumors by comparative genomic hybridization.
|
Cancer Res
|
2003
|
1.65
|
|
10
|
Estrogen receptor beta expression is associated with tamoxifen response in ERalpha-negative breast carcinoma.
|
Clin Cancer Res
|
2007
|
1.54
|
|
11
|
CD40 is a potential marker of favorable prognosis in patients with diffuse large B-cell lymphoma treated with immunochemotherapy.
|
Leuk Lymphoma
|
2010
|
1.41
|
|
12
|
Targeting HMG-CoA reductase with statins in a window-of-opportunity breast cancer trial.
|
Breast Cancer Res Treat
|
2013
|
1.38
|
|
13
|
Adverse effect of adjuvant tamoxifen in premenopausal breast cancer with cyclin D1 gene amplification.
|
Cancer Res
|
2005
|
1.34
|
|
14
|
CD44 isoforms are heterogeneously expressed in breast cancer and correlate with tumor subtypes and cancer stem cell markers.
|
BMC Cancer
|
2011
|
1.31
|
|
15
|
Global H3K27 trimethylation and EZH2 abundance in breast tumor subtypes.
|
Mol Oncol
|
2012
|
1.24
|
|
16
|
Tumor-specific expression of vascular endothelial growth factor receptor 2 but not vascular endothelial growth factor or human epidermal growth factor receptor 2 is associated with impaired response to adjuvant tamoxifen in premenopausal breast cancer.
|
J Clin Oncol
|
2005
|
1.23
|
|
17
|
Dose-volume relationships between enteritis and irradiated bowel volumes during 5-fluorouracil and oxaliplatin based chemoradiotherapy in locally advanced rectal cancer.
|
Acta Oncol
|
2007
|
1.18
|
|
18
|
Molecular profiling reveals low- and high-grade forms of primary melanoma.
|
Clin Cancer Res
|
2012
|
1.17
|
|
19
|
Epidermal growth factor receptor (EGFR) and the estrogen receptor modulator amplified in breast cancer (AIB1) for predicting clinical outcome after adjuvant tamoxifen in breast cancer.
|
Breast Cancer Res Treat
|
2007
|
1.14
|
|
20
|
Prognostic impact of array-based genomic profiles in esophageal squamous cell cancer.
|
BMC Cancer
|
2008
|
1.12
|
|
21
|
Knowledge about hereditary nonpolyposis colorectal cancer; mutation carriers and physicians at equal levels.
|
BMC Med Genet
|
2009
|
1.10
|
|
22
|
The prognostic value of Ki67 is dependent on estrogen receptor status and histological grade in premenopausal patients with node-negative breast cancer.
|
Mod Pathol
|
2009
|
1.07
|
|
23
|
Numb protein expression correlates with a basal-like phenotype and cancer stem cell markers in primary breast cancer.
|
Breast Cancer Res Treat
|
2009
|
1.07
|
|
24
|
Nuclear Janus-activated kinase 2/nuclear factor 1-C2 suppresses tumorigenesis and epithelial-to-mesenchymal transition by repressing Forkhead box F1.
|
Cancer Res
|
2010
|
1.05
|
|
25
|
Quantitative measurement of epidermal growth factor receptor is a negative predictive factor for tamoxifen response in hormone receptor positive premenopausal breast cancer.
|
J Clin Oncol
|
2007
|
1.04
|
|
26
|
Biomarker expression and St Gallen molecular subtype classification in primary tumours, synchronous lymph node metastases and asynchronous relapses in primary breast cancer patients with 10 years' follow-up.
|
Breast Cancer Res Treat
|
2013
|
1.02
|
|
27
|
Comparison of immunohistochemical and biochemical assay of steroid receptors in primary breast cancer--clinical associations and reasons for discrepancies.
|
Acta Oncol
|
2003
|
1.02
|
|
28
|
Evaluation of the tissue microarray technique for immunohistochemical analysis in rectal cancer.
|
Arch Pathol Lab Med
|
2002
|
0.99
|
|
29
|
Indistinguishable genomic profiles and shared prognostic markers in undifferentiated pleomorphic sarcoma and leiomyosarcoma: different sides of a single coin?
|
Lab Invest
|
2009
|
0.98
|
|
30
|
Cytogenetic characterization and gene expression profiling of the trastuzumab-resistant breast cancer cell line JIMT-1.
|
Cancer Genet Cytogenet
|
2007
|
0.98
|
|
31
|
Ki67 proliferation in core biopsies versus surgical samples - a model for neo-adjuvant breast cancer studies.
|
BMC Cancer
|
2011
|
0.98
|
|
32
|
Tamoxifen reduces the risk of contralateral breast cancer in premenopausal women: Results from a controlled randomised trial.
|
Eur J Cancer
|
2009
|
0.95
|
|
33
|
Distinct sets of gene alterations in endometrial carcinoma implicate alternate modes of tumorigenesis.
|
Cancer
|
2002
|
0.94
|
|
34
|
A prospective study of different types of hormone replacement therapy use and the risk of subsequent breast cancer: the women's health in the Lund area (WHILA) study (Sweden).
|
Cancer Causes Control
|
2003
|
0.94
|
|
35
|
Genome-wide search for breast cancer linkage in large Icelandic non-BRCA1/2 families.
|
Breast Cancer Res
|
2010
|
0.93
|
|
36
|
Immunohistochemical patterns in rectal cancer: application of tissue microarray with prognostic correlations.
|
Int J Cancer
|
2004
|
0.93
|
|
37
|
Improved prognostication in soft tissue sarcoma: independent information from vascular invasion, necrosis, growth pattern, and immunostaining using whole-tumor sections and tissue microarrays.
|
Hum Pathol
|
2005
|
0.92
|
|
38
|
Estrogen and progesterone receptor assay in paraffin-embedded breast cancer--reproducibility of assessment.
|
Acta Oncol
|
2003
|
0.90
|
|
39
|
The prognostic value of mitotic activity index (MAI), phosphohistone H3 (PPH3), cyclin B1, cyclin A, and Ki67, alone and in combinations, in node-negative premenopausal breast cancer.
|
PLoS One
|
2013
|
0.90
|
|
40
|
Expression profiling using tissue microarray in 211 malignant fibrous histiocytomas confirms the prognostic value of Ki-67.
|
Virchows Arch
|
2004
|
0.89
|
|
41
|
High tumor tissue concentration of plasminogen activator inhibitor 2 (PAI-2) is an independent marker for shorter progression-free survival in patients with early stage endometrial cancer.
|
Int J Cancer
|
2002
|
0.88
|
|
42
|
Reproducibility of human epidermal growth factor receptor 2 analysis in primary breast cancer: a national survey performed at pathology departments in Sweden.
|
Acta Oncol
|
2009
|
0.88
|
|
43
|
Vascular endothelial growth factor is a strong predictor of early distant recurrences in a prospective study of premenopausal women with lymph-node negative breast cancer.
|
Breast
|
2008
|
0.88
|
|
44
|
St Gallen molecular subtypes in primary breast cancer and matched lymph node metastases--aspects on distribution and prognosis for patients with luminal A tumours: results from a prospective randomised trial.
|
BMC Cancer
|
2013
|
0.87
|
|
45
|
Analysis of and prognostic information from disseminated tumour cells in bone marrow in primary breast cancer: a prospective observational study.
|
BMC Cancer
|
2012
|
0.87
|
|
46
|
Pooled analysis of prognostic impact of uPA and PAI-1 in breast cancer patients.
|
Thromb Haemost
|
2003
|
0.87
|
|
47
|
A novel model for Ki67 assessment in breast cancer.
|
Diagn Pathol
|
2014
|
0.86
|
|
48
|
Mapping of a novel ocular and cutaneous malignant melanoma susceptibility locus to chromosome 9q21.32.
|
J Natl Cancer Inst
|
2005
|
0.86
|
|
49
|
Prediction of outcome after diagnosis of metachronous contralateral breast cancer.
|
BMC Cancer
|
2011
|
0.86
|
|
50
|
Training artificial neural networks directly on the concordance index for censored data using genetic algorithms.
|
Artif Intell Med
|
2013
|
0.86
|
|
51
|
Can tissue microarray-based analysis of protein expression predict recurrence of stage Ta bladder cancer?
|
Scand J Urol Nephrol
|
2011
|
0.86
|
|
52
|
Ezrin expression predicts local recurrence and development of metastases in soft tissue sarcomas.
|
J Clin Pathol
|
2011
|
0.86
|
|
53
|
Low-dose hormone therapy and carbohydrate metabolism.
|
Fertil Steril
|
2003
|
0.85
|
|
54
|
Amplification of the cyclin D1 gene is associated with tumour subsite, DNA non-diploidy and high S-phase fraction in squamous cell carcinoma of the head and neck.
|
Oral Oncol
|
2004
|
0.83
|
|
55
|
Prediction of patient outcome with 2-deoxy-2-[18F]fluoro-D-glucose-positron emission tomography early during radiotherapy for locally advanced cervical cancer.
|
Int J Gynecol Cancer
|
2009
|
0.83
|
|
56
|
Comparison of cisplatin sensitivity and the 18F fluoro-2-deoxy 2 glucose uptake with proliferation parameters and gene expression in squamous cell carcinoma cell lines of the head and neck.
|
J Exp Clin Cancer Res
|
2009
|
0.83
|
|
57
|
HER2 status in hormone receptor positive premenopausal primary breast cancer adds prognostic, but not tamoxifen treatment predictive, information.
|
Breast Cancer Res Treat
|
2007
|
0.82
|
|
58
|
Genes associated with the tumour microenvironment are differentially expressed in cured versus primary chemotherapy-refractory diffuse large B-cell lymphoma.
|
Br J Haematol
|
2008
|
0.82
|
|
59
|
Preoperative staging of locally advanced bladder cancer before radical cystectomy using 3 tesla magnetic resonance imaging with a standardized protocol.
|
Scand J Urol
|
2012
|
0.82
|
|
60
|
Combination of the proliferation marker cyclin A, histological grade, and estrogen receptor status in a new variable with high prognostic impact in breast cancer.
|
Breast Cancer Res Treat
|
2011
|
0.81
|
|
61
|
Focus on the tumour periphery in MRI evaluation of soft tissue sarcoma: infiltrative growth signifies poor prognosis.
|
Sarcoma
|
2006
|
0.81
|
|
62
|
An effect from anticipation also in hereditary nonpolyposis colorectal cancer families without identified mutations.
|
Cancer Epidemiol
|
2009
|
0.80
|
|
63
|
Improved DNA flow cytometric, DNA ploidy, and S-phase reproducibility between 15 laboratories in analysis of breast cancer using generalized guidelines.
|
Cytometry A
|
2003
|
0.80
|
|
64
|
Ezrin expression in rectal cancer predicts time to development of local recurrence.
|
Int J Colorectal Dis
|
2012
|
0.79
|
|
65
|
Tensile strength of surgical knots performed with the da Vinci surgical robot.
|
J Minim Invasive Gynecol
|
2010
|
0.79
|
|
66
|
CD40 expression identifies a prognostically favourable subgroup of diffuse large B-cell lymphoma.
|
Leuk Lymphoma
|
2007
|
0.79
|
|
67
|
Validation of a self-concept scale for Lynch syndrome in different nationalities.
|
J Genet Couns
|
2011
|
0.78
|
|
68
|
Histological specificity of alterations and expression of KIT and KITLG in non-small cell lung carcinoma.
|
Genes Chromosomes Cancer
|
2013
|
0.78
|
|
69
|
The value of bladder mapping and prostatic urethra biopsies for detection of carcinoma in situ (CIS).
|
BJU Int
|
2011
|
0.78
|
|
70
|
Extended lymph node dissection in patients with urothelial cell carcinoma of the bladder: can it make a difference?
|
World J Urol
|
2009
|
0.78
|
|
71
|
High tumor tissue concentration of urokinase plasminogen activator receptor is associated with good prognosis in patients with ovarian cancer.
|
Int J Cancer
|
2003
|
0.77
|
|
72
|
The combination of Ki67, histological grade and estrogen receptor status identifies a low-risk group among 1,854 chemo-naïve women with N0/N1 primary breast cancer.
|
Springerplus
|
2013
|
0.77
|
|
73
|
High preoperative plasma concentration of tissue plasminogen activator (tPA) is an independent marker for shorter overall survival in patients with ovarian cancer.
|
Gynecol Oncol
|
2003
|
0.77
|
|
74
|
The prevalence of immunohistochemically determined oestrogen receptor positivity in primary breast cancer is dependent on the choice of antibody and method of heat-induced epitope retrieval - prognostic implications?
|
Acta Oncol
|
2013
|
0.76
|
|
75
|
Efficient and reproducible identification of mismatch repair deficient colon cancer: validation of the MMR index and comparison with other predictive models.
|
BMC Clin Pathol
|
2013
|
0.76
|
|
76
|
G protein-coupled estrogen receptor is apoptotic and correlates with increased distant disease-free survival of estrogen receptor-positive breast cancer patients.
|
Clin Cancer Res
|
2013
|
0.76
|
|
77
|
Detecting EGFR alterations in clinical specimens-pitfalls and necessities.
|
Virchows Arch
|
2013
|
0.75
|
|
78
|
Blood pharmacokinetics of various monoclonal antibodies labeled with a new trifunctional chelating reagent for simultaneous conjugation with 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetic acid and biotin before radiolabeling.
|
Clin Cancer Res
|
2005
|
0.75
|
|
79
|
A plea for surgical lymph node staging in advanced prostate cancer.
|
Eur Urol
|
2012
|
0.75
|
|
80
|
[Quality assured HER2 analysis in breast cancer. Important therapeutic predictive and prognostic factor].
|
Lakartidningen
|
2008
|
0.75
|
|
81
|
Highly reproducible results of breast cancer biomarkers when analysed in accordance with national guidelines - a Swedish survey with central re-assessment.
|
Acta Oncol
|
2015
|
0.75
|
|
82
|
Benefits from membership in cancer patient associations: relations to gender and involvement.
|
Acta Oncol
|
2006
|
0.75
|